COSCIENS Biopharma Inc.【CSCIF】

Market cap

$87.12M

P/E ratio

	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Revenues (note 6)	1	27	1	4	5	6	4	10
Cost of sales	-	2	0	2	0	0	0	5
Gross profit	-	25	-	-	-	-	-	5
Research and development	11	3	2	2	7	13	14	8
Selling, general and administrative	-	-	-	-	-	-	-	10
Impairment of property and equipment (note 11)	-	-	-	-	-	-	-	1
Impairment of intangible assets (note 12)	-	-	-	-	-	-	-	3
Total expenses	24	15	11	9	14	29	23	23
Profit (loss) from operations	-23	10	-10	-6	-9	-24	-18	-18
Foreign exchange gain (loss)	1	1	0	1	0	1	-0	0
Finance costs	-	-	-	-	-	-	-	0
Interest income	-	-	-	-	-	-	1	0
Other income (expenses)	-	-	-	-	-	-	-	0
Change in fair value of warrant and DSU liabilities	-	-	-	-	-	-	-	3
Other income	3	1	4	1	0	1	1	3
(Loss) Income before income taxes	-20	10	-6	-5	-8	-23	-17	-15
Income tax recovery (expense) (note 21)	-3	5	-0	0	-0	-	-	0
Net Income (loss)	-17	4	-6	-5	-8	-23	-17	-15
Foreign currency translation adjustments	-1	-0	0	-1	0	-0	-0	-1
Actuarial loss on defined benefit plans and remeasurement of the net defined benefit liability (note 15)	1	0	-1	-1	-4	5	-1	-1
Comprehensive loss	-18	4	-7	-7	-12	-18	-18	-17
(Loss) income per share – Basic (note 24)	-	0.25	-0.35	-0.12	-0.07	-4.68	-3.41	-5.93
(Loss) income per share – Diluted (note 24)	-	0.24	-0.35	-0.12	-0.07	-	-3.41	-5.93